This site is intended for healthcare professionals

Go to /sign-in page

You can view 5 more pages before signing in

Go to /pro/cpd-dashboard page

This page is worth 0.05 CPD credits. CPD dashboard

Go to /account/subscription-details page

This page is worth 0.05 CPD credits. Upgrade to Pro

Antigen presenting cells

Last reviewed dd mmm yyyy. Last edited dd mmm yyyy

Authoring team

An early event in the mounting of an immune response, is the presentation of foreign antigen to lymphocytes with their subsequent activation. This occurs by the action of various cells listed below:

  • macrophages
  • epidermal dendritic Langerhans' cells
  • Kupffer cells in the Liver
  • microglial cells
  • microfold M cells of intestinal Peyer's patches

The most common of these is the macrophage, which phagocytoses cell debris and processes antigens from potentially pathogenic organisms.

Antigens are then placed on the surface of the macrophage or other antigen presenting cell, and are presented to lymphocytes, bound to one of the body's own self-recognition antigens.

The latter are products of the major histocompatibility complex, MHC, and on antigen presenting cells are of the class II variety. The combination of foreign antigen bound to MHC class II molecule then leads to lymphocyte activation.

Lymphocytes (such as B cells and T-helper cells) will have antigen presented to them, initiating the adaptive response.

Neutrophils are also antigen presenting cells (APCs).

 


Create an account to add page annotations

Annotations allow you to add information to this page that would be handy to have on hand during a consultation. E.g. a website or number. This information will always show when you visit this page.

The content herein is provided for informational purposes and does not replace the need to apply professional clinical judgement when diagnosing or treating any medical condition. A licensed medical practitioner should be consulted for diagnosis and treatment of any and all medical conditions.

Connect

Copyright 2024 Oxbridge Solutions Limited, a subsidiary of OmniaMed Communications Limited. All rights reserved. Any distribution or duplication of the information contained herein is strictly prohibited. Oxbridge Solutions receives funding from advertising but maintains editorial independence.